STXS : Summary for STEREOTAXIS INC COM USD0.001 - Yahoo Finance

U.S. Markets close in 46 mins.

Stereotaxis, Inc. (STXS)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.61-0.01 (-1.16%)
As of 1:57PM EST. Market open.
People also watch
HNSNSPNCNUROSTAAROSG
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.62
Open0.62
Bid0.00 x
Ask0.00 x
Day's Range0.61 - 0.63
52 Week Range0.47 - 1.95
Volume77,347
Avg. Volume48,763
Market Cap13.42M
Beta1.98
PE Ratio (TTM)-0.71
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswireyesterday

    First Site in Japan to Install Stereotaxis Technology Completes 250 Procedures

    LOUIS, Feb. 23, 2017-- Stereotaxis, Inc., a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that Takatsuki General Hospital, a leading acute care ...

  • GlobeNewswire8 days ago

    Montreal Heart Institute Implements Stereotaxis Technologies

    LOUIS, Feb. 16, 2017-- Stereotaxis, Inc., a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, and the Montreal Heart Institute, an internationally recognized research ...

  • American City Business Journals18 days ago

    Cortex-based medical device maker's CEO resigns

    William C. Mills III has resigned as CEO of Stereotaxis, the St. Louis-based medical device maker that operates out of the Cortex innovation district. Mills also resigned his board seat at the company, which develops medical devices for treating cardiac arrhythmias. David Fischel has been named acting CEO and chairman of the board, effective immediately.